Compare Abeona Therapeutics Inc (ABEO) vs Nebius Group NV (NBIS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Abeona Therapeutics Inc vs Nebius Group NV — how do they compare? Abeona Therapeutics Inc trades at $7.57 (market cap $421.19M), while Nebius Group NV trades at $220.1 (market cap $49.06B). The key difference: Nebius Group NV is far larger — about 116.5× Abeona Therapeutics Inc's market cap, and Abeona Therapeutics Inc is trading nearer its 52-week high, Nebius Group NV nearer its low. Which is the better fit depends on your goals.
| ABEO | NBIS | |
|---|---|---|
Market Cap | $421.19M | $49.06B |
Sector | Health | Technology |
52-Week High | $7.45 | $286.69 |
52-Week Low | $4.17 | $64.06 |
Enterprise Value | $276.10M | $49.26B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Abeona Therapeutics Inc
Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.
Read more on ABEO →About Nebius Group NV
Nebius Group N.V. is a technology company specializing in AI, machine learning, and cloud computing solutions. The company provides a range of enterprise-level cloud services, including large-scale data processing, advanced analytics, and AI model development and deployment. Nebius Group focuses on serving businesses that require high-performance, scalable, and secure infrastructure to handle complex computational tasks and accelerate their digital transformation.
Read more on NBIS →
